Updates

INDIA GLYCOLS LIMITED Plot No. 2-8B. Sector - 126, NOIDA-201304, Distt. Gautam Budh Nagar (Uttar Pradesh), Tel. : +91 (120) 6860000, 3090100, 3090200 Fax : +91 (120) 3090111, 3090211, E-mail : igiho@indiaglycols.com, Website : www.indiaglycols.com IGL/SE/2026-27/59 8th September, 2026 The Manager (Listing) The Manager (Listing) BSE Limited National Stock Exchange of India Limited 1# Floor, New Trading Ring, Exchange Plaza, C-1, Block G, Rotunda Building, P.J. Towers, Bandra Kurla Complex, Dalal Street, Mumbai - 400 001 Bandra (East), Mumbai- 400 051 Scrip Code: 500201 Symbol: INDIAGLYCO Dear Sirs, Sub.: Material Update in Connection with Ennature Bio Pharma Limited with reference to Observation letter no. NSE/LIST/48932 dated 17t November, 2025 and no. DCS/AMAL/TS/R37/3905/2025-26 dated 19" November, 2025 ("Observation Letters”), issued by the National Stock Exchange of India Limited and BSE Limited (collectively the "Stock Exchanges”), respectively, received in relation to the Scheme of Arrangement. With reference to captioned above, we would like to inform you that Ennature Bio Pharma Limited (“EBL"), through its lefter dated 8t September, 2026, has communicated to the Company certain material events/ updates in relation to EBL, which is enclosed herein as Annexure A. This disclosure is being made in respect of EBL, pursuant to the requirement in the Observation Letters and SEBI Master Circular No. HO/4911 411 4(7)2025-CFD-POD211 13762/2026 dated 30" January, 2026 (as amended). You are requested to kindly take the same on record. Thanking you, Yours faithfully, For India Glycols Limited Ankur Jain Head (Legal) & Company Secretary Encl: A/a Corporate Office : 3A, Shakespeare Sarani, Kolkata - 700071, Phone : +91 33 22823585, 22823586 Works & Registered Office : A-1, Industrial Area, Bazpur Road, Kashipur - 244713, Distt. Udham Singh Nagar (Uttarakhand) Phone : +91 5947 269000 / 269500 Fax : +91 5947 275315, 269535 CIN : L24111UR1983PLC009097 Annexure A ENNATURE BIO PHARMA LIMITED {Formerly known as Ennature Bio Pharma Private Limited) Plot No. 2-B, Sector-126, Noida- 201304, Distt. Gautam Budh Nagar, Uttar Pradesh, Tel.: +91 120 3090100, 3090200, 6860000 Fax: +91 120 3090111, 3090211 E-mail: connect@ennature.com, Website: www.ennaturebiopharma.com 8th September, 2026 India Glycols Limited Plot No. 2-B, Sector- 126, Noida-201304 Sub: Material update in connection with the Scheme of Arrangement amongst India Glycols Limited and Ennature Bio Pharma Llimited (the Company) and IGL Spirits Limited and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act, 2013 ("Scheme”). Dear Sirs, This is to inform you that the Board of Directors of the Company, at its meeting held on 8" September, 2026, has inter- alia, approved the following: i. Allotment of 2,23,42,255 (Two Crore Twenty Three Lakh Forty two Thousand two Hundred Fifty-Five) fully paid-up equity shares of INR 5/- each in the ratio of 1:3 to the eligible shareholders of India Glycols Limited whose names appeared in the Register of Members/Register of Beneficial Owners as on the Record Date, i.e., 2nd September, 2026, in accordance with the terms of the Scheme of Arrangement ("Scheme”). The aforesaid equity shares as allotted shall rank pari passu in all respects, with the existing equity shares of the Company. i. Appointment of Shri Ajay Sharma as Chief Financial Officer & Key Managerial Personnel of the Company. iil. Appointment of Smt. Preeti Choudhary as Company Secretary, Key Managerial Personnel & Compliance Officer of the Company. iv. Appointment of M/s Mukesh Agarwal & Co., Company Secretaries as Secretarial Auditor of the Company, subject to the approval of members of the Company, for a period 5 (five) consecutive years from FY 2026-27 to 2030-31. v. Appointment of M/s S.S. Kothari Mehta & CO. LLP, Chartered Accountants as Internal Auditor of the Company for the financial year 2026-27. vi. Approval of Information Memorandum for making necessary application with the Stock Exchanges for listing and obtaining trading approval in respect of the aforesaid equity shares allotted pursuant to the Scheme. Necessary details as required under Master Circular No. HO/49/14114(7)2025-CFD- POD2/]/3762/2026 dated 30" January, 2026 are enclosed herewith as Annexure A. Registered Office: P.No. 4, Pharma City, Selaqui-248197, Dehradun, Uttarakhand, India Phone: +91 135-2698620, Fax: +91 135 2698939; CIN: U24290UR2021PLCO13005 ENNATURE BIO PHARMA LIMITED {Formerly known as Ennature Bio Pharma Private Limited) Plot No. 2-B, Sector-126, Noida- 201304, Distt. Gautam Budh Nagar, Uttar Pradesh, Tel.: +91 120 3030100, 3090200, 6860000 Fax: +91 120 3090111, 3090211 E-mail: connect@ennature.com, Website: www.ennaturebiopharma.com TR 15 TOT yOUT INformation. Thanking You. Yours faithfully, For Ennature Bio Pharma Limited Preeti Choudhary Company Secretary & Compliance Officer Registered Office: P.No. 4, Pharma City, Selaqui-248197, Dehradun, Uttarakhand, India Phone: +91 135-2698620, Fax: +91 135 2698939; CIN: U24290UR2021PLC013005 Annexure A Details of Key Managerial Personnels, Secretarial Auditor and Internal Auditor: Name Shri Ajay Sharma Reason for change (appointment, Appointed as Chief Financial Officer resighation+emoval-death-orotherwise) Date of appointment and term of September 08, 2026 appointment Brief profile He is a seasoned Business finance professional with (in case of appointment) over 20+ years of Experience across the Pharma & Automotive industries. He was associated with India Glycols Ltd since Nov'2021. He holds a master's in business administration in Finance & a Bachelor of Commerce frgm Delhi University. His expertise is in corporate finance, strategic treasury management, Taxation and enterprise risk governance. Prior to stepping into the new role of Chief Financial Officer, he held senior leadership positions driving financial planning and analysis (FP&A), regulatory compliance, Fund Management & working capital, ERP/digital transformations, and operational cost optimization across the industries. Disclosure of relationships between Nil directors (in case of appointment of a director) Name Smt. Preeti Choudhary Reason for change (appointment, Appointed as Company Secretary & Compliance resignationfemoval-death-orotherwise) Officer Date of appointment and term of 8h September, 2026 appointment Brief profile Smt. Preeti Choudhary (ACS: 21658) aged 44 year (09t (in case of appointment) August, 1981) is an Associate Member of Institute of Company Secretaries of India. She is also a law graduate. She has hands-on experience in Corporate Secretarial, Listing Compliances, Merger & Demergers, Corporate Law, Compliance Management, RBI compliance w.r.t. NBFC. She also served as Company Secretary at Kashipur Holdings Limited, promoter of India Glycols Limited. Her prior assignments include Runeecha Textiles Limited, NTT Communications India Networks, PACL India Limited giving her exposure across both listed and private company environments. Disclosure of relationships between Nil directors (in case of appointment of a director) Name M/s_Mukesh Agarwal & Co., Company Secretaries Reason for change (appointment, Appointed as Secretarial Auditor ighatl i death otherwise) Date of appointment and term of 8fh September, 2026 for a period of 5 (five) consecutive appointment years from FY 2026-27 to 2030-31, subject to shareholders approval. Brief profile M/s. Mukesh Agarwal & CO., Companies Secretaries, (in case of appointment) bearing firm registration number $2001DE039700 and Peer Review Certificate No.: 1875/2022, is a Partnership Firm of practicing company secretaries. M/s. Mukesh Agarwal & CO. was Founded in 2001, It is a premier firm of Practising Company Secretaries committed to delivering comprehensive corporate and secretarial services with extensive experience in advising and supporting domestic and international clients. They are committed to en [Showing first 8,000 characters — download PDF for full document]